Zhenling Yao

1.5k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Zhenling Yao is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Zhenling Yao has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Zhenling Yao's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Asthma and respiratory diseases (4 papers) and Dermatology and Skin Diseases (3 papers). Zhenling Yao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Asthma and respiratory diseases (4 papers) and Dermatology and Skin Diseases (3 papers). Zhenling Yao collaborates with scholars based in United States, Belgium and Netherlands. Zhenling Yao's co-authors include William J. Jusko, Debra C. DuBois, Jonathan M. Edelman, Berend C. Stoel, Noel G. McElvaney, James Stocks, Robert A. Sandhaus, Eeva Piitulainen, Kenneth R. Chapman and Jonathan Burdon and has published in prestigious journals such as The Lancet, Blood and Cancer Research.

In The Last Decade

Zhenling Yao

27 papers receiving 1.1k citations

Hit Papers

Intravenous augmentation treatment and lung density in se... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
    2015 325 citations Kenneth R. Chapman, Jonathan Burdon et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenling Yao United States 14 478 335 241 195 194 27 1.2k
Antje Lebrecht Germany 23 407 0.9× 181 0.5× 215 0.9× 305 1.6× 147 0.8× 58 1.4k
Yong Meng China 11 491 1.0× 207 0.6× 90 0.4× 100 0.5× 131 0.7× 38 1.0k
Jingsong Wang China 23 729 1.5× 114 0.3× 216 0.9× 209 1.1× 129 0.7× 81 1.4k
Margret Rave‐Fränk Germany 25 732 1.5× 361 1.1× 199 0.8× 343 1.8× 395 2.0× 89 1.9k
M Zerilli Italy 18 725 1.5× 127 0.4× 239 1.0× 349 1.8× 111 0.6× 31 1.4k
Jie Deng China 21 259 0.5× 192 0.6× 528 2.2× 172 0.9× 160 0.8× 77 1.5k
Brian M. Nolen United States 21 547 1.1× 127 0.4× 282 1.2× 364 1.9× 138 0.7× 28 1.6k
Shuling Zhang China 20 445 0.9× 119 0.4× 251 1.0× 144 0.7× 328 1.7× 75 1.2k
Yuki Niwa Japan 20 493 1.0× 84 0.3× 178 0.7× 148 0.8× 136 0.7× 58 1.3k
Markku H. Vaarala Finland 22 572 1.2× 90 0.3× 238 1.0× 220 1.1× 552 2.8× 53 1.5k

Countries citing papers authored by Zhenling Yao

Since Specialization
Citations

This map shows the geographic impact of Zhenling Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenling Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenling Yao more than expected).

Fields of papers citing papers by Zhenling Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenling Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenling Yao. The network helps show where Zhenling Yao may publish in the future.

Co-authorship network of co-authors of Zhenling Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenling Yao. A scholar is included among the top collaborators of Zhenling Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenling Yao. Zhenling Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qi, Jian Zhang, Haijun Zhong, et al.. (2023). Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma. Cancer Immunology Immunotherapy. 72(8). 2729–2739. 1 indexed citations
2.
Vollenhoven, Ronald van, Bevra H. Hahn, George C. Tsokos, et al.. (2021). Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study. The Journal of Rheumatology. 49(4). 380–387. 22 indexed citations
3.
Jordan, Jarrat, Jacqueline Benson, W. Winn Chatham, et al.. (2020). First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial. The Lancet Rheumatology. 2(10). e613–e622. 10 indexed citations
4.
5.
Nnane, Ivo, Bart Frederick, Zhenling Yao, et al.. (2020). The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis. British Journal of Clinical Pharmacology. 86(12). 2507–2518. 34 indexed citations
6.
Hu, Chuanpu, Zhenling Yao, Yang Chen, et al.. (2018). A comprehensive evaluation of exposure–response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasis. Journal of Pharmacokinetics and Pharmacodynamics. 45(4). 523–535. 16 indexed citations
7.
Chapman, Kenneth R., Jonathan Burdon, Eeva Piitulainen, et al.. (2015). Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. The Lancet. 386(9991). 360–368. 325 indexed citations breakdown →
8.
Tricoci, Pierluigi, Denise D’Andrea, Paul A. Gurbel, et al.. (2015). Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial. Journal of the American Heart Association. 4(8). e002171–e002171. 95 indexed citations
9.
Zhang, Yi Xin, Zhenling Yao, Peter Kuebler, et al.. (2014). Pharmacokinetics of Ranibizumab after Intravitreal Administration in Patients with Retinal Vein Occlusion or Diabetic Macular Edema. Ophthalmology. 121(11). 2237–2246. 29 indexed citations
10.
Zhang, Ying, Tharin Limsakun, Debra M. Bensen-Kennedy, Alex Veldman, & Zhenling Yao. (2014). Population Pharmacokinetic Modeling and Simulation of Recombinant Single-Chain Factor VIII (r VIII-SingleChain) in Patients with Hemophilia a. Blood. 124(21). 2814–2814. 1 indexed citations
11.
Wang, Bing, Meina Liang, Zhenling Yao, et al.. (2012). Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 102(1). 250–261. 8 indexed citations
12.
Forero, Andres, Mehdi Hamadani, Michelle A. Fanale, et al.. (2012). MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study. Blood. 120(21). 3677–3677. 3 indexed citations
13.
Khawli, Leslie A., Ryan Hutchinson, Jihong Yang, et al.. (2010). Charge variants in IgG1. mAbs. 2(6). 613–624. 340 indexed citations
14.
Yao, Zhenling, et al.. (2009). Prevention of Laser Photocoagulation Induced Choroidal Neovascularization Lesions by Intravitreal Doses of Ranibizumab in Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 50(13). 785–785. 2 indexed citations
15.
Yao, Zhenling, Eric P. Hoffman, Svetlana Ghimbovschi, et al.. (2008). Pharmacodynamic/Pharmacogenomic Modeling of Insulin Resistance Genes in Rat Muscle after Methylprednisolone Treatment: Exploring Regulatory Signaling Cascades. PubMed. 2. 141–61. 3 indexed citations
16.
Yao, Zhenling, Baiteng Zhao, Eric P. Hoffman, et al.. (2007). Application of Scaling Factors in Simultaneous Modeling of Microarray Data from Diverse Chips. Pharmaceutical Research. 24(4). 643–649. 4 indexed citations
17.
Yao, Zhenling, Debra C. DuBois, Richard R. Almon, & William J. Jusko. (2007). Pharmacokinetic/Pharmacodynamic Modeling of Corticosterone Suppression and Lymphocytopenia by Methylprednisolone in Rats. Journal of Pharmaceutical Sciences. 97(7). 2820–2832. 28 indexed citations
18.
Almon, Richard R., Debra C. DuBois, Zhenling Yao, et al.. (2007). Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiological Genomics. 30(3). 282–299. 48 indexed citations
19.
Yao, Zhenling, Debra C. DuBois, Richard R. Almon, & William J. Jusko. (2006). Modeling Circadian Rhythms of Glucocorticoid Receptor and Glutamine Synthetase Expression in Rat Skeletal Muscle. Pharmaceutical Research. 23(4). 670–679. 46 indexed citations
20.
Yao, Zhenling, Wojciech Krzyżański, & William J. Jusko. (2006). Assessment of Basic Indirect Pharmacodynamic Response Models with Physiological Limits. Journal of Pharmacokinetics and Pharmacodynamics. 33(2). 167–193. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antje Lebrecht Breakdown of academic impact, for papers by Yong Meng Breakdown of academic impact, for papers by Jingsong Wang Breakdown of academic impact, for papers by Margret Rave‐Fränk Breakdown of academic impact, for papers by M Zerilli Breakdown of academic impact, for papers by Jie Deng Breakdown of academic impact, for papers by Brian M. Nolen Breakdown of academic impact, for papers by Shuling Zhang Breakdown of academic impact, for papers by Yuki Niwa Breakdown of academic impact, for papers by Markku H. Vaarala
Rankless by CCL
2026